Avalyn Pharma Inc.
AVLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001540171
No open-market purchases or sales by Avalyn Pharma Inc. insiders were filed in the last 90 days; 93 institutions reported holding it in 13F filings for Q2 2026, worth $1.46B in total; Soros Fund Management is the only superinvestor holding it.
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:28 PM ET
No financial statements
Avalyn Pharma Inc. has no annual statements on file yet. See the quarterly statements.